The European Medicines Agency has launched a public consultation on Good Pharmacovigilance Practices. The draft guidelines are intended to support the preparation of educational materials which are required as part of risk minimisation measures for authorised medicinal products. It is expected that the guidelines will be implemented in the quarter of 2015.
Please click here to view the draft guidelines.
Sign up to our email digest